Research Topic · Peer-Reviewed

Plasmid Construction

Plasmid construction is an essential technique used in both Hematology and Oncology Research. Plasmids are small DNA molecules that are used to carry foreign genetic material into host cells, and they play a critical role in genetic engineering. These circular pieces of DNA are typically found in bacteria, but they …

Curated from this journal's research 📚 1 peer-reviewed article cited Cited 2× across the literature 🔖 ISSN 2372-6601 🗓 Reviewed July 2026

Overview

Plasmid construction is an essential technique used in both Hematology and Oncology Research. Plasmids are small DNA molecules that are used to carry foreign genetic material into host cells, and they play a critical role in genetic engineering. These circular pieces of DNA are typically found in bacteria, but they can also be artificially constructed in the lab. In hematology research, plasmid construction is used to create genetic vectors that can be used to introduce specific genes into blood cells. For example, researchers may use plasmids to introduce genes that produce anti-tumor proteins into T cells, which can then be used in immunotherapy treatments for cancer patients. Similarly, in oncology research, plasmid construction is used to create vectors that can deliver therapeutic genes to cancer cells. These vectors can be engineered to target specific types of cancer cells, and they can also be designed to release therapeutic agents that kill cancer cells. To construct a plasmid, researchers use a series of techniques that involve cutting and splicing DNA sequences. These sequences may be taken from existing plasmids or from other sources, and they may be modified using techniques like PCR (polymerase chain reaction) or site-directed mutagenesis. Overall, plasmid construction is an essential technique for both Hematology and Oncology Research, as it enables researchers to create vectors that can deliver genes and therapeutic agents to specific cells. By using these vectors, researchers are making progress towards new treatments for cancer and other blood-related diseases.

Research published in this journal

1 peer-reviewed article, ranked by relevance. Each links to its DOI.

How this research is being cited

The 1 article above has been cited 2 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Plasmid Construction, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.